{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:59:46Z","timestamp":1791914386778,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA262375"],"award-info":[{"award-number":["R01CA262375"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is highly prevalent, affecting approximately 11% of US adults. Multiple studies have evaluated a potential association between CKD and urinary tract malignancies. Summary estimates of urinary tract malignancy risk in CKD patients with and without common co-existing conditions may guide clinical practice recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Four electronic databases were searched for original cohort studies evaluating the association between CKD and urinary tract cancers (kidney cancer and urothelial carcinoma) through 25 May 2023, in persons with at least moderate CKD and no dialysis or kidney transplantation. Quality assessment was performed for studies meeting inclusion criteria using the Newcastle-Ottawa Scale. Meta-analysis with a random-effects model was performed for unadjusted incidence rate ratios (IRR) as well as adjusted hazard ratios (aHR) for confounding conditions (diabetes, hypertension and\/or tobacco use), shown to have association with kidney cancer and urothelial carcinoma. Sub-analysis was conducted for estimates associated with CKD stages separately.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Six cohort studies with 8\u00a0617\u00a0563 persons were included. Overall, the methodological quality of the studies was good. CKD was associated with both higher unadjusted incidence and adjusted hazard of kidney cancer (IRR 3.36, 95% confidence interval (CI) 2.32\u20134.88; aHR 2.04, 95% CI 1.77\u20132.36) and urothelial cancer (IRR 3.96, 95% CI 2.44\u20136.40; aHR 1.35, 95% CI 1.22\u20131.50) compared with persons without CKD. Examining incident urinary tract cancers by CKD severity, risks were elevated in stage 3 CKD (kidney aHR 1.89, 95% CI 1.56\u20132.30; urothelial carcinoma aHR 1.35, 95% CI 1.20\u20131.52) as well as in stages 4\/5 CKD (kidney cancer aHR 2.30, 95% CI 2.00\u20132.66; urothelial carcinoma aHR 1.24, 95% CI 1.04\u20131.49).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Even moderate CKD is associated with elevated risk of kidney cancer and urothelial carcinoma. Providers should consider these elevated risks when managing individuals with CKD, particularly when considering evaluation for the presence and etiology of hematuria.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad249","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T08:39:57Z","timestamp":1701419997000},"page":"1023-1033","source":"Crossref","is-referenced-by-count":15,"title":["Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis"],"prefix":"10.1093","volume":"39","author":[{"given":"Emily R","family":"Brooks","sequence":"first","affiliation":[{"name":"Department of Radiology, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutita","family":"Siriruchatanon","sequence":"additional","affiliation":[{"name":"Department of Radiology, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Department of Radiology, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Charytan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-3787","authenticated-orcid":false,"given":"Stella K","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Radiology, NYU Grossman School of Medicine , New York, NY , USA"},{"name":"Department of Population Health, NYU Grossman School of Medicine , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"2024053023531834900_bib1","doi-asserted-by":"crossref","first-page":"e207932","DOI":"10.1001\/jamanetworkopen.2020.7932","article-title":"National trends in the prevalence of chronic kidney disease among racial\/ethnic and socioeconomic status groups, 1988-2016","volume":"3","author":"Vart","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024053023531834900_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2024053023531834900_bib3","volume-title":"USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","author":"United States Renal Data System","year":"2022"},{"key":"2024053023531834900_bib4","volume-title":"Chronic Kidney Disease in the United States","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2024053023531834900_bib5","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1681\/ASN.2014101034","article-title":"Cause-specific deaths in non-dialysis-dependent CKD","volume":"26","author":"Navaneethan","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2024053023531834900_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.23876\/j.krcp.18.0131","article-title":"Risk of cancer in pre-dialysis chronic kidney disease: a nationwide population-based study with a matched control group","volume":"38","author":"Park","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"2024053023531834900_bib7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Wong","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2024053023531834900_bib8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer","volume":"25","author":"Lowrance","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2024053023531834900_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2024053023531834900_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","article-title":"Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand","volume":"14","author":"Stewart","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2024053023531834900_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet North Am Ed"},{"key":"2024053023531834900_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.juro.2013.04.130","article-title":"Risk factors for renal cell carcinoma in the VITAL study","volume":"190","author":"Macleod","year":"2013","journal-title":"J Urol"},{"key":"2024053023531834900_bib13","doi-asserted-by":"crossref","first-page":"18336","DOI":"10.1038\/s41598-022-23225-6","article-title":"Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men","volume":"12","author":"Teleka","year":"2022","journal-title":"Sci Rep"},{"key":"2024053023531834900_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.canep.2011.02.014","article-title":"Diabetes and urothelial cancer risk: the Multiethnic Cohort study","volume":"35","author":"Woolcott","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"2024053023531834900_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.ki.5002017","article-title":"Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study","volume":"71","author":"Yamagata","year":"2007","journal-title":"Kidney Int"},{"key":"2024053023531834900_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"2024053023531834900_bib17","volume-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses","author":"Wells","year":"2000"},{"key":"2024053023531834900_bib18","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1168","article-title":"Mixed effects Poisson regression models for meta-analysis of follow-up studies with constant or varying durations","volume":"5","author":"Bagos","year":"2009","journal-title":"Int J Biostat"},{"key":"2024053023531834900_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1109\/TR.1973.5216041","article-title":"An empirical Bayes approach for the Poisson life distribution","volume":"R-22","author":"Canavos","year":"1973","journal-title":"IEEE Trans Rel"},{"key":"2024053023531834900_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-015-0031-0","article-title":"Meta-analysis of incidence rate data in the presence of zero events","volume":"15","author":"Spittal","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"2024053023531834900_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Methods"},{"key":"2024053023531834900_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.6028\/jres.087.022","article-title":"Consensus values and weighting factors","volume":"87","author":"Paule","year":"1982","journal-title":"J Res Natl Bur Stand"},{"key":"2024053023531834900_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"2024053023531834900_bib24","doi-asserted-by":"crossref","first-page":"e0263661","DOI":"10.1371\/journal.pone.0263661","article-title":"Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes","volume":"17","author":"Hebert","year":"2022","journal-title":"PLoS One"},{"key":"2024053023531834900_bib25","volume-title":"RStudio: Integrated Development Publication for R. RStudio","author":"R Core Team","year":"2022"},{"key":"2024053023531834900_bib26","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R news"},{"key":"2024053023531834900_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/9781119536604.ch10","article-title":"Analysing data and un-dertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2019","edition":"2nd edition"},{"key":"2024053023531834900_bib28","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1002\/sim.7372","article-title":"Measuring the statistical validity of summary meta-analysis and meta-regression results for use in clinical practice","volume":"36","author":"Willis","year":"2017","journal-title":"Stat Med"},{"key":"2024053023531834900_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.ajkd.2022.02.020","article-title":"Cancer risk and mortality in patients with kidney disease: a population-based cohort study","volume":"80","author":"Kitchlu","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024053023531834900_bib30","doi-asserted-by":"crossref","first-page":"e3255","DOI":"10.1097\/MD.0000000000003255","article-title":"Chronic kidney disease is associated with upper tract urothelial carcinoma: a nationwide population-based cohort study in Taiwan","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024053023531834900_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2021.02.004","article-title":"The association between renal function decline and the incidence of urothelial carcinoma: a 16-year retrospective cohort study in Taiwan","volume":"27","author":"Chuang","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"2024053023531834900_bib32","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.7150\/jca.47175","article-title":"Association between kidney function and the risk of cancer: results from the China Health and Retirement longitudinal study (CHARLS)","volume":"11","author":"Liu","year":"2020","journal-title":"J Cancer"},{"key":"2024053023531834900_bib33","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/aje\/kwab140","article-title":"Associations between kidney function, proteinuria, and the risk of kidney cancer: a nationwide cohort study involving 10 million participants","volume":"190","author":"Park","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2024053023531834900_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"2024053023531834900_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1442-2042.2009.02302.x","article-title":"2009 update on the classification of renal epithelial tumors in adults","volume":"16","author":"Lopez-Beltran","year":"2009","journal-title":"Int J Urol"},{"key":"2024053023531834900_bib36","doi-asserted-by":"crossref","first-page":"F1477","DOI":"10.1152\/ajprenal.00327.2009","article-title":"Cell biology and physiology of the uroepithelium","volume":"297","author":"Khandelwal","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024053023531834900_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/gfr749","article-title":"Haematuria: the forgotten CKD factor?","volume":"27","author":"Moreno","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2024053023531834900_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-018-0951-0","article-title":"Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"19","author":"Orlandi","year":"2018","journal-title":"BMC Nephrol"},{"key":"2024053023531834900_bib39","doi-asserted-by":"crossref","first-page":"e0128575","DOI":"10.1371\/journal.pone.0128575","article-title":"Haematuria increases progression of advanced proteinuric kidney disease","volume":"10","author":"Yuste","year":"2015","journal-title":"PLoS One"},{"key":"2024053023531834900_bib40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: aua\/sufu guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"2024053023531834900_bib41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.juro.2018.04.065","article-title":"Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria?","volume":"200","author":"Tan","year":"2018","journal-title":"J Urol"},{"key":"2024053023531834900_bib42","volume-title":"Bladder Cancer (Version 2.2022)","author":"National Comprehensive Care Network","year":"2022"},{"key":"2024053023531834900_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2013.07.008","article-title":"Reduced estimated GFR and cancer mortality","volume":"63","author":"Iff","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2024053023531834900_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2024053023531834900_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"key":"2024053023531834900_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cjp2.96","article-title":"Tumour cell expression of interleukin 6 receptor \u03b1 is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma","volume":"4","author":"Pilskog","year":"2018","journal-title":"J Pathol Clin Res"},{"key":"2024053023531834900_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-5347(05)64741-6","article-title":"Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome","volume":"168","author":"Horiguchi","year":"2002","journal-title":"J Urol"},{"key":"2024053023531834900_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/528690","article-title":"Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer","volume":"2012","author":"Zhu","year":"2012","journal-title":"Mediators Inflamm"},{"key":"2024053023531834900_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2215\/CJN.10820918","article-title":"Estimated glomerular filtration rate and the risk of cancer","volume":"14","author":"Xu","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024053023531834900_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2532-6","article-title":"Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies","volume":"16","author":"Wong","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad249\/56336131\/gfad249.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/6\/1023\/58008281\/gfad249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/6\/1023\/58008281\/gfad249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T01:08:22Z","timestamp":1717117702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/39\/6\/1023\/7456597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11,30]]},"published-print":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad249","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2023,11,30]]}}}